|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/05/21 Anika Therapeutics, Inc. 10-K 12/31/20 105:11M Globenewswire Inc./FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 1.34M
6: EX-10.13D Material Contract HTML 94K
7: EX-10.13E Material Contract HTML 93K
8: EX-10.13G Material Contract HTML 85K
9: EX-10.13H Material Contract HTML 93K
2: EX-23.1 Consent of Expert or Counsel HTML 29K
3: EX-31.1 Certification -- §302 - SOA'02 HTML 35K
4: EX-31.2 Certification -- §302 - SOA'02 HTML 36K
5: EX-32.1 Certification -- §906 - SOA'02 HTML 30K
16: R1 Document And Entity Information HTML 89K
17: R2 Consolidated Balance Sheets HTML 112K
18: R3 Consolidated Balance Sheets (Parentheticals) HTML 47K
19: R4 Consolidated Statements of Operations and HTML 108K
Comprehensive Income (Loss)
20: R5 Consolidated Statements of Stockholders' Equity HTML 85K
21: R6 Consolidated Statements of Cash Flows HTML 152K
22: R7 Note 1 - Nature of Business HTML 35K
23: R8 Note 2 - Summary of Significant Accounting HTML 118K
Policies
24: R9 Note 3 - Business Combinations HTML 100K
25: R10 Note 4 - Fair Value Measurements HTML 90K
26: R11 Note 5 - Inventories HTML 44K
27: R12 Note 6 - Property and Equipment HTML 44K
28: R13 Note 7 - Acquired Intangible Assets, Net HTML 85K
29: R14 Note 8 - Goodwill HTML 47K
30: R15 Note 9 - Leases HTML 79K
31: R16 Note 10 - Accrued Expenses HTML 43K
32: R17 Note 11 - Revolving Credit Agreement HTML 35K
33: R18 Note 12 - Commitments and Contingencies HTML 34K
34: R19 Note 13 - Revenue by Product Group, by Significant HTML 87K
Customer and by Geographic Location; Geographic
Information
35: R20 Note 14 - Equity Incentive Plan HTML 108K
36: R21 Note 15 - Employee Benefit Plan HTML 33K
37: R22 Note 16 - Accelerated Share Repurchases HTML 36K
38: R23 Note 17 - Income Taxes HTML 120K
39: R24 Note 18 - Earnings Per Share ("Eps") HTML 43K
40: R25 Note 19 - Quarterly Financial Data (Unaudited) HTML 67K
41: R26 Significant Accounting Policies (Policies) HTML 171K
42: R27 Note 2 - Summary of Significant Accounting HTML 52K
Policies (Tables)
43: R28 Note 3 - Business Combinations (Tables) HTML 81K
44: R29 Note 4 - Fair Value Measurements (Tables) HTML 85K
45: R30 Note 5 - Inventories (Tables) HTML 42K
46: R31 Note 6 - Property and Equipment (Tables) HTML 42K
47: R32 Note 7 - Acquired Intangible Assets, Net (Tables) HTML 79K
48: R33 Note 8 - Goodwill (Tables) HTML 39K
49: R34 Note 9 - Leases (Tables) HTML 76K
50: R35 Note 10 - Accrued Expenses (Tables) HTML 41K
51: R36 Note 13 - Revenue by Product Group, by Significant HTML 86K
Customer and by Geographic Location; Geographic
Information (Tables)
52: R37 Note 14 - Equity Incentive Plan (Tables) HTML 102K
53: R38 Note 17 - Income Taxes (Tables) HTML 115K
54: R39 Note 18 - Earnings Per Share ("Eps") (Tables) HTML 40K
55: R40 Note 19 - Quarterly Financial Data (Unaudited) HTML 65K
(Tables)
56: R41 Note 2 - Summary of Significant Accounting HTML 72K
Policies (Details Textual)
57: R42 Note 2 - Summary of Significant Accounting HTML 39K
Policies - Allowance for Doubtful Accounts
(Details)
58: R43 Note 2 - Summary of Significant Accounting HTML 39K
Policies - Estimated Useful Lives of Property and
Equipment (Details)
59: R44 Note 3 - Business Combinations (Details Textual) HTML 74K
60: R45 Note 3 - Business Combinations - Consideration HTML 41K
Transferred (Details)
61: R46 Note 3 - Business Combinations - Fair Value of Net HTML 74K
Assets Acquired (Details)
62: R47 Note 3 - Business Combinations - Intangible Assets HTML 43K
Acquired (Details)
63: R48 Note 3 - Business Combinations - Pro Forma HTML 32K
Information (Details)
64: R49 Note 4 - Fair Value Measurements (Details Textual) HTML 68K
65: R50 Note 4 - Fair Value Measurements - Fair Value of HTML 62K
Financial Instruments (Details)
66: R51 Note 4 - Fair Value Measurements - Contingent HTML 38K
Consideration (Details)
67: R52 Note 5 - Inventories (Details Textual) HTML 34K
68: R53 Note 5 - Inventories - Summary of Inventories HTML 41K
(Details)
69: R54 Note 6 - Property and Equipment (Details Textual) HTML 30K
70: R55 Note 6 - Property and Equipment - Property and HTML 43K
Equipment at Cost (Details)
71: R56 Note 7 - Acquired Intangible Assets, Net (Details HTML 50K
Textual)
72: R57 Note 7 - Acquired Intangible Assets, Net - Summary HTML 63K
of Intangible Assets (Details)
73: R58 Note 8 - Goodwill (Details Textual) HTML 32K
74: R59 Note 8 - Goodwill - Changes in the Carrying Value HTML 38K
of Goodwill (Details)
75: R60 Note 9 - Leases (Details Textual) HTML 32K
76: R61 Note 9 - Leases - Lease Expense and Other HTML 58K
Information (Details)
77: R62 Note 9 - Leases - Future Minimum Rental Payments HTML 95K
for Operating Leases (Details)
78: R63 Note 10 - Accrued Expenses - Summary of Accrued HTML 45K
Expenses (Details)
79: R64 Note 11 - Revolving Credit Agreement (Details HTML 63K
Textual)
80: R65 Note 12 - Commitments and Contingencies (Details HTML 30K
Textual)
81: R66 Note 13 - Revenue by Product Group, by Significant HTML 35K
Customer and by Geographic Location; Geographic
Information (Details Textual)
82: R67 Note 13 - Revenue by Product Group, by Significant HTML 50K
Customer and by Geographic Location; Geographic
Information - Product Revenue by Product Group
(Details)
83: R68 Note 13 - Revenue by Product Group, by Significant HTML 47K
Customer and by Geographic Location; Geographic
Information - Total Revenue by Geographic Location
(Details)
84: R69 Note 13 - Revenue by Product Group, by Significant HTML 34K
Customer and by Geographic Location; Geographic
Information - Net Tangible Long-lived Assets by
Principal Geographic Areas (Details)
85: R70 Note 14 - Equity Incentive Plan (Details Textual) HTML 131K
86: R71 Note 14 - Equity Incentive Plan - Granted and HTML 48K
Exercised Stock-based Compensation Awards
(Details)
87: R72 Note 14 - Equity Incentive Plan - Stock Options HTML 50K
and SAR's Activity (Details)
88: R73 Note 14 - Equity Incentive Plan - Summary of HTML 41K
Exercisable Options and SAR's (Details)
89: R74 Note 14 - Equity Incentive Plan - Restricted Stock HTML 50K
Activity (Details)
90: R75 Note 14 - Equity Incentive Plan - Assumptions Used HTML 42K
to Estimate Fair Value of Stock Options and Stock
Appreciation Rights (Details)
91: R76 Note 14 - Equity Incentive Plan - Total HTML 36K
Stock-based Compensation Expense (Details)
92: R77 Note 15 - Employee Benefit Plan (Details Textual) HTML 33K
93: R78 Note 16 - Accelerated Share Repurchases (Details HTML 72K
Textual)
94: R79 Note 17 - Income Taxes (Details Textual) HTML 59K
95: R80 Note 17 - Income Taxes - Components of Income HTML 63K
Before Taxes and Provision for (Benefit from)
Income Taxes (Details)
96: R81 Note 17 - Income Taxes - Significant Components of HTML 62K
Company's Deferred Tax Assets and Liabilities
(Details)
97: R82 Note 17 - Income Taxes - Reconciliation Between HTML 52K
U.S. Federal Statutory Rate and Effective Rate
(Details)
98: R83 Note 18 - Earnings Per Share ("Eps") (Details HTML 34K
Textual)
99: R84 Note 18 - Earnings Per Share ("EPS") - Basic and HTML 38K
Diluted Earnings Per Share (Details)
100: R85 Note 19 - Quarterly Financial Data (Unaudited) HTML 34K
(Details Textual)
101: R86 Note 19 - Quarterly Financial Data (Unaudited) - HTML 67K
Quarterly Financial Data (Unaudited) (Details)
103: XML IDEA XML File -- Filing Summary XML 199K
15: XML XBRL Instance -- anik20201231_10k_htm XML 2.55M
102: EXCEL IDEA Workbook of Financial Reports XLSX 118K
11: EX-101.CAL XBRL Calculations -- anik-20201231_cal XML 186K
12: EX-101.DEF XBRL Definitions -- anik-20201231_def XML 1.68M
13: EX-101.LAB XBRL Labels -- anik-20201231_lab XML 1.36M
14: EX-101.PRE XBRL Presentations -- anik-20201231_pre XML 1.72M
10: EX-101.SCH XBRL Schema -- anik-20201231 XSD 250K
104: JSON XBRL Instance as JSON Data -- MetaLinks 456± 766K
105: ZIP XBRL Zipped Folder -- 0001171843-21-001573-xbrl Zip 374K
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| This ‘10-K’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 3/5/21 | |||
| For Period end: | 12/31/20 | 10-K/A | ||
| 2/3/20 | 8-K, 8-K/A | |||
| 1/24/20 | 8-K, 8-K/A | |||
| 12/31/19 | 10-K | |||
| 12/31/18 | 10-K | |||
| 5/2/18 | 8-K | |||
| List all Filings | ||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/15/24 Anika Therapeutics, Inc. 10-K 12/31/23 90:9.1M Globenewswire Inc./FA 3/16/23 Anika Therapeutics, Inc. 10-K 12/31/22 97:10M Globenewswire Inc./FA 3/11/22 Anika Therapeutics, Inc. 10-K 12/31/21 105:25M Globenewswire Inc./FA 5/07/21 Anika Therapeutics, Inc. 10-Q 3/31/21 67:5.1M Globenewswire Inc./FA 4/26/21 Anika Therapeutics, Inc. 10-K/A 12/31/20 100:10M Globenewswire Inc./FA |